Literature DB >> 10518497

TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for Vg function in wing formation.

P Vaudin1, R Delanoue, I Davidson, J Silber, A Zider.   

Abstract

The mammalian TEF and the Drosophila scalloped genes belong to a conserved family of transcriptional factors that possesses a TEA/ATTS DNA-binding domain. Transcriptional activation by these proteins likely requires interactions with specific coactivators. In Drosophila, Scalloped (Sd) interacts with Vestigial (Vg) to form a complex, which binds DNA through the Sd TEA/ATTS domain. The Sd-Vg heterodimer is a key regulator of wing development, which directly controls several target genes and is able to induce wing outgrowth when ectopically expressed. Here we show that Vg contains two distinct transcriptional activation domains, suggesting that the function of Vg is to mediate transcriptional activation by Sd. By expressing a chimeric GAL4-Sd protein in Drosophila, we found that the transcriptional activity of the Vg-Sd heterodimer is negatively regulated at the AP and DV boundary of the wing disc. We also identify a novel human protein, TONDU, which contains a short domain homologous to the domain of Vg required for interaction with Sd. We show that TONDU specifically interacts with a domain conserved in all the mammalian TEF factors. Expression of TDU in Drosophila by means of the UAS-GAL4 system shows that this human protein can substitute for Vg in wing formation. We propose that TDU is a specific coactivator for the mammalian TEFs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518497     DOI: 10.1242/dev.126.21.4807

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  43 in total

1.  TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.

Authors:  A Vassilev; K J Kaneko; H Shu; Y Zhao; M L DePamphilis
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

Review 2.  Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.

Authors:  Anwesha Dey; Xaralabos Varelas; Kun-Liang Guan
Journal:  Nat Rev Drug Discov       Date:  2020-06-17       Impact factor: 84.694

3.  A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity.

Authors:  Tong Guo; Yi Lu; Peixue Li; Meng-Xin Yin; Dekang Lv; Wenjing Zhang; Huizhen Wang; Zhaocai Zhou; Hongbin Ji; Yun Zhao; Lei Zhang
Journal:  Cell Res       Date:  2013-09-03       Impact factor: 25.617

4.  Antagonizing scalloped with a novel vestigial construct reveals an important role for scalloped in Drosophila melanogaster leg, eye and optic lobe development.

Authors:  Ankush Garg; Ajay Srivastava; Monica M Davis; Sandra L O'Keefe; Leola Chow; John B Bell
Journal:  Genetics       Date:  2006-11-16       Impact factor: 4.562

5.  VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.

Authors:  Wenjing Zhang; Yijun Gao; Peixue Li; Zhubing Shi; Tong Guo; Fei Li; Xiangkun Han; Yan Feng; Chao Zheng; Zuoyun Wang; Fuming Li; Haiquan Chen; Zhaocai Zhou; Lei Zhang; Hongbin Ji
Journal:  Cell Res       Date:  2014-01-24       Impact factor: 25.617

6.  Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.

Authors:  Cristina R Antonescu; Lei Zhang; G Petur Nielsen; Andrew E Rosenberg; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2011-06-29       Impact factor: 5.006

7.  Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor.

Authors:  Seiichiro Mori; Takamasa Takeuchi; Yoshiyuki Ishii; Takashi Yugawa; Tohru Kiyono; Hiroshi Nishina; Iwao Kukimoto
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 8.  VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.

Authors:  Xiaochong Deng; Lin Fang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

9.  Alternative requirements for Vestigial, Scalloped, and Dmef2 during muscle differentiation in Drosophila melanogaster.

Authors:  Hua Deng; Sarah C Hughes; John B Bell; Andrew J Simmonds
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

10.  Vestigial expression in the Drosophila embryonic central nervous system.

Authors:  Kirsten A Guss; Hemlata Mistry; James B Skeath
Journal:  Dev Dyn       Date:  2008-09       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.